Support metastatic breast cancer research
Breast cancer fundraisers are everywhere, but most of the money raised goes toward breast cancer prevention and early detection efforts. Very little of it, only 2-3%, is dedicated toward research for Stage IV, metastatic breast cancer. METAvivor is the only organization that solely funds MBC research through a scientific peer review process. We appreciate your donation and honor your generosity by ensuring that 100% of your donation goes toward supporting grants for metastatic breast cancer research.
About METAvivor
METAvivor is dedicated to the specific fight for women and men living with stage 4 metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research. While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual stage 4 breast cancer research.
Did You Know?
- Currently, over 230,000 Americans are diagnosed with breast cancer each year
- 5% of those diagnosed with breast cancer are Stage IV at the time of diagnosis
- 30% eventually progress from Stages 0, I, II and III to become Stage IV
- Metastatic breast cancer (MBC) patients live, on average, 18–24 months after diagnosis
- Stage 0 patients can and do metastasize
- Patients can and do metastasize 30 years or more after treatment
- In the US, over 40,000 people die from MBC each year.
Remarkably, despite these dire statistics, research focused on the already metastasized state is funded at only 2–3%.
While there is broad awareness of breast cancer, Stage IV, or metastatic breast cancer is a disease that is rarely acknowledged or discussed. METAvivor is seeking to change this. From speaking with legislators to running national campaigns to increasing awareness, METAvivor is at the forefront of advocating for increased public awareness, greater support, and improved treatments for MBC patients.